25th Annual EuroMeeting

The need to harmonise pharmacopoeial requirements in a globalised world has already been identified in the late 80s. However, the outcome of the Pharmacopoeial Discussion Group, an informal harmonisation initiative set up by three major pharmacopoeias, has yet to meet the pharmacopoeias’ and stakeholders’ expectation. The session will provide an update on industry needs, current harmonisation initiatives and the approaches taken, and will offer a platform for open discussion with the panel of speakers.